AX
Axos Financial, Inc.
AX's outlook is improving, though it still trails on the overall score.
BAC
Bank of America Corporation
BAC has the edge over AX overall, supported by stronger fundamentals and stronger modeled upside.
AX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
AX's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like AX.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
AX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8x | $70.53 | -23% |
| Forward | 9.1x | $91.29 | — |
| Fair | 10x | $88.40 | -3.2% |
| Current | 10x | $91.29 | — |
| Expensive | 13x | $112 | +23% |
Historical ranges are pointers, not guarantees.
AX's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over AX in the historical PE scenario, which offers more potential upside but is not a forecast.
AX Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for AX, with profitability improving.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
AX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $10.03 | +14% |
| Q3 2026 | $8.79 | +18% |
| Q2 2026 | $8.48 | +14% |
| Q1 2026 | $8.20 | +12% |
| Q4 2025 | $7.86 | +6.4% |
| Q3 2025 | $7.44 | -9.4% |
| Q2 2025 | $7.43 | -3% |
| Q1 2025 | $7.29 | -0.7% |
| Q4 2024 | $7.39 | +9.5% |
AX earned $8.79 per share over the past year, up 18% from the year before. Its recent earnings include one-off gains.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over AX on earnings, with more consistent year-over-year improvement.
AX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $395.1M | +22% |
| Q2 2026 | $379.8M | +18% |
| Q1 2026 | $392.2M | +27% |
| Q4 2025 | $385.1M | +25% |
| Q3 2025 | $323.4M | +0.9% |
| Q2 2025 | $321.4M | +10% |
| Q1 2025 | $308.8M | +4.8% |
| Q4 2024 | $307.9M | -13% |
AX's revenue has grown year over year for seven quarters in a row: $395M last quarter, up 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 44% | -2 points |
| Q2 2026 | 41% | -7.4 points |
| Q1 2026 | 42% | -5.8 points |
| Q4 2025 | 46% | -3.2 points |
| Q3 2025 | 46% | -3.3 points |
| Q2 2025 | 48% | -1.2 points |
| Q1 2025 | 48% | -4.8 points |
| Q4 2024 | 49% | -13 points |
AX has the edge over BAC on profitability, with a higher operating margin.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
AX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $235.5M | +115% |
| Q2 2026 | $197.7M | +22% |
| Q1 2026 | -$101.2M | -255% |
| Q4 2025 | $85.4M | -45% |
| Q3 2025 | $109.3M | +106% |
| Q2 2025 | $161.6M | +385% |
| Q1 2025 | $65.1M | -39% |
| Q4 2024 | $156.4M | +52% |
AX has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
AX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +99.3K shares |
| 1 year | +0.4% | +243K shares |
| 3 years | -3.7% | -2.2M shares |
| 5 years | -4.4% | -2.6M shares |
| Available history | -7.4% | -4.6M shares |
AX has 57M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4M |
| Q2 2026 | $22M |
| Q2 2025 | $32.3M |
| Q1 2025 | $25.9M |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | $13.1M |
| Q1 2024 | $595,000 |
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over AX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
AX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.9x | Net Cash |
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | 2.3x | Moderate |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | -1.9x | Net Cash |
| Q2 2025 | -2.5x | Net Cash |
| Q1 2025 | -2.6x | Net Cash |
| Q4 2024 | -3.3x | Net Cash |
AX has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
AX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.6 | Neutral |
| Stochastic | 35.9 | Neutral |
AX's weekly RSI is 49 (neutral) and its Stochastic is 36 (neutral).
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
AX PE vs Financial Services Sector
| Metric | AX | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 13x | 20% below |
| PE % | 53 | 63 | 10 pts below |
AX has the edge over BAC on valuation relative to its sector.
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
AX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $90.0 | 1.4% above |
| 20 week MA | $94.6 | 3.4% below |
| 50 week MA | $91.7 | 0.4% below |
| 100 week MA | $83.4 | 9.4% above |
| 200 week MA | $67.5 | 35% above |
AX has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
AX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.4 | $37.7 | +24% |
| 2021 | $37.7 | $55.1 | +46% |
| 2022 | $55.1 | $37.5 | -32% |
| 2023 | $37.5 | $54.6 | +46% |
| 2024 | $54.6 | $71.3 | +31% |
| 2025 | $71.3 | $88.2 | +24% |
| 2026 YTD | $88.2 | $91.3 | +3.5% |
AX has the edge over BAC on returns for 2026, with the stronger performance.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.